Literature DB >> 21992975

A prospective study of the psychosocial impact of a positive Chlamydia trachomatis laboratory test.

Sami L Gottlieb1, Bradley P Stoner, Akbar A Zaidi, Christina Buckel, Molly Tran, Jami S Leichliter, Stuart M Berman, Lauri E Markowitz.   

Abstract

BACKGROUND: Few data exist on potential harms of chlamydia screening. We assessed the psychosocial impact of receiving a positive Chlamydia trachomatis test result.
METHODS: We prospectively studied women ≥16 years of age undergoing chlamydia testing in 2 Midwestern family planning clinics. We surveyed women at baseline and about 1 month after receiving test results, using 9 validated psychosocial scales/subscales and chlamydia-specific questions. Changes in scale scores were calculated for each woman. Mean percent changes in scores for chlamydia-positive and -negative women were compared using a t test.
RESULTS: We enrolled 1807 women (response rate, 84%). Of the 1688 women with test results, 149 (8.8%) tested positive. At follow-up, chlamydia-positive women (n = 71) had a 75% increase in anxiety about sexual aspects of their life on the Multidimensional Sexual Self-Concept Questionnaire (P < 0.001), significantly greater than the 26% increase among 280 randomly selected chlamydia-negative women (P = 0.02). There were no differences for the other 8 scales/subscales, including general measures of anxiety, depression, and self-esteem. Chlamydia-positive women were more likely than chlamydia-negative women to be "concerned about chlamydia" (80% vs. 40%, P < 0.001) and to report breaking up with a main partner (33% vs. 11%, P < 0.001) at follow-up. Women testing positive reported a range of chlamydia-specific concerns.
CONCLUSIONS: Chlamydia-positive women had significant increases in anxiety about sex and concern about chlamydia, but did not have marked changes in more general measures of psychosocial well-being about 1 month after diagnosis. Chlamydia diagnoses were associated with some disruption of relationships with main partners. Chlamydia-specific concerns may guide counseling messages to minimize psychosocial impact.

Entities:  

Mesh:

Year:  2011        PMID: 21992975     DOI: 10.1097/OLQ.0b013e31822b0bed

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  9 in total

Review 1.  Screening for genital chlamydia infection.

Authors:  Nicola Low; Shelagh Redmond; Anneli Uusküla; Jan van Bergen; Helen Ward; Berit Andersen; Hannelore Götz
Journal:  Cochrane Database Syst Rev       Date:  2016-09-13

2.  Continuing Need for Sexually Transmitted Disease Clinics After the Affordable Care Act.

Authors:  Karen W Hoover; Bradley W Parsell; Jami S Leichliter; Melissa A Habel; Guoyu Tao; William S Pearson; Thomas L Gift
Journal:  Am J Public Health       Date:  2015-10-08       Impact factor: 9.308

3.  De-Sexualizing Partner Notification: A Qualitative Study on Chinese Young Adults with Chlamydia.

Authors:  Bobo H P Lau; Lucia Liu; Celia H Y Chan; Cecilia L W Chan; Jason J Ong; Eleanor Holroyd; William C W Wong
Journal:  Int J Environ Res Public Health       Date:  2021-04-12       Impact factor: 3.390

4.  Recommendation on screening for chlamydia and gonorrhea in primary care for individuals not known to be at high risk.

Authors:  Ainsley Moore; Gregory Traversy; Donna L Reynolds; John J Riva; Guylène Thériault; Brenda J Wilson; Melissa Subnath; Brett D Thombs
Journal:  CMAJ       Date:  2021-04-19       Impact factor: 8.262

5.  Screening for chlamydia and/or gonorrhea in primary health care: systematic reviews on effectiveness and patient preferences.

Authors:  Jennifer Pillay; Aireen Wingert; Tara MacGregor; Michelle Gates; Ben Vandermeer; Lisa Hartling
Journal:  Syst Rev       Date:  2021-04-19

6.  Toward global prevention of sexually transmitted infections (STIs): the need for STI vaccines.

Authors:  Sami L Gottlieb; Nicola Low; Lori M Newman; Gail Bolan; Mary Kamb; Nathalie Broutet
Journal:  Vaccine       Date:  2014-02-25       Impact factor: 3.641

7.  High Prevalence of Chlamydia and Gonorrhea and the Need for Sexually Transmitted Infection Testing Among Men Who Have Sex With Men and Transgender Women in Papua New Guinea.

Authors:  Avi J Hakim; Chelsea Iwamoto; Steven G Badman; Barne Willie; Simon Pekon; Herick Aeno; Ruthy Neo-Boli; Sophie Ase; Damian Weikum; Andrew J Vallely; Angela Kelly-Hanku
Journal:  Sex Transm Dis       Date:  2021-02-01       Impact factor: 3.868

8.  Health-related quality of life and psychosocial impacts of a diagnosis of non-specific genital infection in symptomatic heterosexual men attending UK sexual health clinics: a feasibility study.

Authors:  Sebastian S Fuller; Syed Tariq Sadiq; Rachel Hill-Tout; Emma M Harding-Esch; Agata Pacho; Martina Furegato
Journal:  BMJ Open       Date:  2018-06-30       Impact factor: 2.692

9.  Identifying youth at high risk for sexually transmitted infections in community-based settings using a risk prediction tool: a validation study.

Authors:  Katharina Kranzer; Victoria Simms; Ethel Dauya; Ioana D Olaru; Chido Dziva Chikwari; Kevin Martin; Nicol Redzo; Tsitsi Bandason; Mandikudza Tembo; Suzanna C Francis; Helen A Weiss; Richard J Hayes; Constancia Mavodza; Tsitsi Apollo; Gertrude Ncube; Anna Machiha; Rashida Abbas Ferrand
Journal:  BMC Infect Dis       Date:  2021-12-08       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.